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SteroidogenesisAdiponectin is an abundantly circulating adipokine, orchestrating its effects through two 7-transmembrane
receptors (AdipoR1 and AdipoR2). Steroidogenesis is regulated by a variety of neuropeptides and adipokines.
Earlier studies have reported adipokine mediated steroid production. A key rate-limiting step in
steroidogenesis is cholesterol transportation across the mitochondrial membrane by steroidogenic acute
regulatory protein (StAR). Several signalling pathways regulate StAR expression. The actions of adiponectin
and its role in human adrenocortical steroid biosynthesis are not fully understood. The aim of this studywas to
investigate the effects of adiponectin on StAR protein expression, steroidogenic genes, and cortisol production
and to dissect the signalling cascades involved in the activation of StAR expression. Using qRT-PCR, Western
blot analysis and ELISA, we have demonstrated that stimulation of human adrenocortical H295R cells with
adiponectin results in increased cortisol secretion. This effect is accompanied by increased expression of key
steroidogenic pathway genes including StAR protein expression via ERK1/2 and AMPK-dependent pathways.
This has implications for our understanding of adiponectin receptor activation and peripheral steroidogenesis.
Finally, our study aims to emphasise the key role of adipokines in the integration of metabolic activity and
energy balance partly via the regulation of adrenal steroid production.: + 44 2476 523701.
. Randeva).
ll rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Adiponectin, a recently discovered adipokine circulates abundant-
ly in human plasma [1]. In contrast to other adipokines, adiponectin
levels are inversely correlated with bodymass index, percentage body
fat and visceral fat; adiponectin is also signiﬁcantly reduced in
obesity-related disease states such as type 2 diabetes [1]. Adiponectin
binds and activates two transmembrane adiponectin receptors
(ADIPORs 1 and 2), which share a 66% homology in their amino acid
sequence [1].
In non-obese healthy men, serum adiponectin exhibits ultradian
and circadian variations preceding or matching closely to that of
cortisol, suggesting a potential feedback loop between adiponectin
and cortisol secretions [2]. Interestingly, adiponectin receptors are
expressed in the human adrenal gland [3]; however the functional
relevance of the ADIPORs within the adrenal gland is currently not
known. Adiponectin also increases IGF-1 induced progesterone
secretion in chicken ovary [4] and in rat ovarian granulosa cells [5],suggesting that adiponectin plays a signiﬁcant role in the biosynthesis
of steroid hormones.
Previous studies from Bornstein's group have shown how certain
adipokines regulate steroidogenesis in an adrenal cell-line [6].
Steroidogenesis involves transcription and activation of various
enzymes required for this successive breakdown of cholesterol. The
ﬁrst key mediator of steroidogenesis is the 30 kDa steroidogenic acute
regulatory (StAR) protein [7]. StAR is abundantly expressed in the
steroid-producing cells, required for the transportation of cholesterol
across the mitochondrial membrane (an obligatory step for steroid
production) [8]. Reduction in StAR expression is the only known cause
of the steroid-deﬁciency disease, familial lipoid adrenal hyperplasia
[9].
A number of proteins are known to stimulate or inhibit StAR
expression, including ACTH, insulin, neuropeptide-Y orexin, TNF-
alpha, TGF-B and angiotensin [10–12] through the action of multiple
signalling pathways [11,13]. These signalling pathways include AMPK,
AKT and various MAPK cascades including those mediated by ERK1/2
and p38. This variation may reﬂect the effects of different agonistic
sites within the full length adiponectin molecule either at each of the
two ADIPORs or possibly utilising even further receptor complexity.
Table 1
Nucleotide sequences of PCR primer used in the study.
Name Sence Antisence Product size (bp)
StAR 5′-GGCTACTCAGCATCGACCTC-3′ 5′-CATCCCACTGTCACCAGATG-3′ 249
Cyp11a 5′-TGGGACAGACGAGTGA-3′ 5′-AGAGTTGAAATCCAACACC-3′ 202
HSD3B2 5′-ACCGCCACACAGTCACATTA-3′ 5′-CCCACATGCACATCTCTGTC-3′ 196
Cyp21a2 5′-GAGTTCTGTGAGCGCA-3′ 5′-CACGTCCACAATTTGGAT-3′ 200
Cyp17 5′-GTGACCGTAACCGTCT-3′ 5′-ATGAACTGATCCGGCT-3′ 205
Cyp11B1 5′-TTTCTCCAGCAAGCACTGTCC-3′ 5′-GGACAAAACCACAGCACCCTT-3′ 102
GAPDH 5′-TGAACGGGAAGCTCACTGG-3′ 5′-TCCACCACCCTGTTGCTGTA-3′ 306
ADIPOR1 5′-CGGTGGAACTGGCTGAACTG-3′ 5′-CCGCACCTCCTCCTCTTCTT-3′ 125
ADIPOR2 5′-ACGGAGTTGTCAGCACTCAC-3′ 5′-GCCATCGTCTTGTACCTCAC-3′ 108
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domain on cortisol release through direct regulation of steroidogenesis
in the adrenal H295R cell line. H295R cells are a widely accepted
pluripotent adrenal model expressing all of the key enzymatic stages of
steroidogenesis.We showevidence for expression of bothADIPOR1 and
ADIPOR2 in this cell-line and show that the effects on cortisol secretion
are concomitant with an AMPK, ERK1/2-mediated up-regulation of the
ﬁrst mediator of cholesterol metabolism, the steroidogenic acute
regulatory (StAR) protein. This study increases our understanding of
the agonistic properties of the adiponectinmolecule andmay represent
a potentially important therapeutic peptide domain.
2. Materials and methods
2.1. Biochemical reagents and inhibitors
Insulin, transferring, seleniumandUltraserum-G (PALL Life Sciences,
Cergy, France), growth supplement for H295R cells, were obtained from
Sigma-Aldrich Co. Ltd. (Gillingham, Dorset, UK). Accutase required for
splitting cellswasobtained fromTCSCellworks (Buckinghamshire, UK),
and ECL plusWestern blotting detection reagentswere fromAmersham
Biosciences (Buckinghamshire, UK). Agarose was obtained from MBI
Fermentas (York, UK) and Helena BioSciences Europe (Tyne & Wear,
UK). Adiponectin (15–36) was obtained from Phoenix Pharmaceuticals
(Cat no: 028–55) (Belmont, CA). Precision Plus Protein Standard was
from Bio-Rad Laboratories Ltd. (Hertfordshire, UK). Polyvinylidene
diﬂuoride (PVDF) membrane was purchased from Amersham Bios-
ciences; all of the primers were obtained from TAGN (Newcastle, UK).
Camptothecin was obtained from Calbiochem (Darmstadt, Germany).
Following inhibitors were obtained from Calbiochem (Darmstadt,
Germany): Compound C a potent and speciﬁc inhibitor of AMP kinase
and U0126, a potent and speciﬁc inhibitor of MEK1 and MEK2.
2.2. Cell culture
H295Rhumanadrenocortical cellswere cultured inH295R complete
media containing DMEM/F12 (1:1) supplemented with 2% Ultroser G
(Biosepra, Villeneuve-la-Garenne, France) and ITS (Discovery Labware,
Bedford, MA), in six-well plates for 24 h after reaching conﬂuence.
Medium was replaced with 2 ml fresh medium containing different
cytokines and cultured for 4 and 24 h, unless otherwise indicated. At the
end of the incubation period, cells were washed with ice-cold PBS and
subjected to RNA or protein extraction and analysis as described below.
2.3. RT-PCR
Total RNA was extracted using the Qiagen RNeasy Mini Kit and
reverse-transcribed into cDNAaspreviously described [14]. Adiponectin
receptor(s) and steroidogenic gene expression was measured by
RT-PCR, using 1 μg RNA and random primers as reverse transcription
primers. A control reaction which omitted reverse transcriptase was
included to check for the presence of genomic DNA. Steroidogenic gene,ADIPOR1 and ADIPOR2 expressions were ampliﬁed using a Hybrid
Thermal Cycler in a 50 ml reaction medium containing 1 unit of Taq
polymerase (Fermentas, York, UK), 20 pmol of each sense and anti-
sense primer and dNTP (10 mmol/l each), using the following cycling
conditions: 94 °C for 1 min, then38cycles of 94 °C for 60 s, 60 °C for 45 s,
and 72 °C for 30 s, followed by a 10 min extension at 72 °C. The
sequences for the sense and anti-sense primers are shown in Table 1.
PCR products were stained with ethidium bromide and visualised by
electrophoresis through 1.5% agarose gels. Sequencing of the PCR
products conﬁrmed the sequence identities.
2.4. Quantiﬁcation of mRNA
The concentrations of target mRNAs were measured by reverse
transcription followed by real-time PCR performed on a Roche Light
Cycler system (Roche Molecular Biochemicals, Mannheim, Germany).
Table 1 describes the primers used for this study. PCRs were carried out
using 2.5 ml cDNA in a 5.5 ml PCR SYBR Green-1 Light Cycler ‘Master
Mix’ (Biogene, Cambridgeshire, UK) and 1 ml sense and anti-sense
primers. For studies involving steroidogenic gene expression H295R
cells were incubated with adiponectin (100 nmol/l) for 4 h. A series of
three dilutions for each cDNA was used to ensure linear ampliﬁcation.
Protocol conditions consistedof denaturation of 958 C for 60 s, followed
by 40 cycles of 94 8 C for 1 s, 60 8 C for 8 s, and 72 8 C for 15 s, followed
by melting-curve analysis. For analysis, quantitative amounts of the
genes of interest were standardised against the housekeeping gene
GAPDH. Negative controls for all the reactions included preparations
lacking cDNAor RNA-lacking reverse transcriptase in place of the cDNA.
The relative mRNA levels were expressed as a ratio using ‘Delta–delta
method’ for comparing relative expression results between treatments
in real-time PCR [15].
2.5. Western blotting
Protein lysates were prepared by adding equal amounts of Laemmli
buffer (5 M urea, 0.17 M SDS, 0.4 M dithiothreitol, and 50 mMTris–HCl,
pH 8.0) to each well, and samples were denatured by sonication and
boiling. Samples were separated by SDSPAGE (10% resolving gel) and
transferred to polyvinylidene diﬂuoride (Millipore (U.K.) Limited,
Watford, UK)membranes at 100 V for 1 h in a transfer buffer containing
20 mM Tris, 150 mM glycine, and 20%methanol. The PVDFmembranes
were incubatedwithprimary antibody for adiponectin receptors 1 and2
(Alpha Diagnostics Intl. Inc, San Antonio, USA) at 1:1500 dilution and
β-actin (Abcam plc, Cambridge, UK) at 1:25,000was used as control for
loading made up in Tris buffered saline (TBS)-0.1% Tween (TBST), and
5% BSA overnight at 4 °C. For experiments involving StAR protein the
primary antibody StAR (Abcam plc, Cambridge, UK) was used at a
1:7000 dilution and β-actin (Abcam plc, Cambridge, UK) at 1:25,000
dilution in Tris buffered saline (TBS)-0.1% Tween (TBST), and 5% BSA
overnight at 4 °C. All the membranes were washed, incubated with a
secondary anti-rabbit (ADIPOR1 and ADIPOR2), anti-rabbit (StAR),
anti-mouse (β-actin, Abcam plc, Cambridge, UK) horseradish
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and washed for 60 min with TBST. Antibody complexes were visualised
using an ECL Plus chemiluminescence detection kit (GE Healthcare UK
Ltd, Buckinghamshire, UK). The densities were measured using a
scanning densitometer coupled to a Scion Image scanning software
(Scion Corporation, Frederick, MD, USA).2.6. Cortisol measurements
For cortisol release experiments H295R human adrenocortical cells
were cultured in H295R complete media containing DMEM/F12 (1:1)
supplemented with 2% Ultroser G (Biosepra, Villeneuve-la-Garenne,
France) and ITS (Discovery Labware, Bedford, MA), in six-well plates
until the cells were about 80–85% conﬂuence. Then cells were serum
starved overnight in media containing DMEM/F12 (1:1) supplemented
with ITS and noUltroser G for overnight. Following overnight starvation
the medium was replaced with a 2 ml fresh medium containing
adiponectin (100 nmol/l) or (angiotensin 100 nmol/l) and cultured for
24 h,unless otherwise indicated. At the endof the incubationperiod, the
supernatant was taken and snap frozen immediately and stored
at −80°C until the cortisol measurements were done. Cortisol
measurements were done using the ELISA kit according to the
manufacturer's instructions (ALPCO Cortisol EIA kit, Paris, France).2.7. Cell-Titre Glo proliferation assay for analysis of adiponectin-mediated
proliferation of H295R cells
H29R cells were seeded on a 96-well plate at 1×104 cells per well in
quadruplet and allowed to grow for 24 h followed with serum
starvation overnight. Prior to treatment with 100 nM adiponectin for
24 h at 37 °C/5%CO2, the cellswere allowed to grow in serumcontaining
media for 24 h followedwith serum starvation overnight. The Cell-Titre
Glo assay (Promega, Southampton, UK)was performed according to the
manufacturer's instructions. Following incubation, proliferation was
quantiﬁed via bioluminescence using a luminometer. Cells stimulated
with vehicle and non-seeded wells containing media alone were
included as a control.2.8. Statistical analysis
Data are shown as the means±SE from 4 different experiments.
One-way ANOVAwas used formultiple group comparisons followed by a
Tukey's test for post hoc analysis. To analyse measurements of the
intensity of immunoreactive staining, a scanning densitometer was used
(Scion Image; Scion, Frederick, MD, USA). The values were considered
signiﬁcant if the differences in themeans between the control and treated
groups were greater than the P-value b0.05 (*Pb0.05; **Pb0.01;
***Pb0.01).Fig. 1. The detection of ADIPOR1 and ADIPOR2 genes and protein in H295R cells. The A) and B
products from reverse transcribed RNA using primers for ADIPOR1 (125 bp) and ADIPOR2 (108
H295R cells. A) Human subcutaneous adipose tissue (ADR, lane 1), H295R cells (lane 2), and n
(lane 2), and negative control (lane 3). C) ADIPOR1 1) H295R cells, 2) human subcutaneou
D) ADIPOR2 1) H295R cells, 2) human subcutaneous adipose tissue lysates, 3)HEK293-ADIPOR3. Results
3.1. Adiponectin receptors are expressed in H295R cells
The expression of adiponectin receptors in human adrenocortical
H295R cells was analysed by RT-PCR and Western blot analysis. Fig. 1A
andB shows clearmRNAand protein (Fig. 1C andD) expressions of both
adiponectin receptors (ADIPOR1 and ADIPOR2) in the H295R adrenal
cell-line, concomitant with that observed for the native human adrenal
tissue [17]. Fig. 1A shows a representative ethidiumbromide-stained gel
showing a 125 bp PCR product for the ADIPOR1 and a 108 bp PCR
product for theADIPOR2. Bandswere excised, puriﬁedand sequenced to
conﬁrm their identity. Analysis of protein byWestern blotting revealed
a band of 42 kDa for ADIPOR1 and 35 kDa for ADIPOR2 in both H295R
cells and adipose tissue which was used as positive control. This
suggests that this pluripotent cell model of adrenal steroidogenesis is
also representative of an adiponectin-sensitive model of the adrenal
tissue.
3.2. Adiponectin causes cortisol secretion from H295R cells
To assess the role of adiponectin on cortisol production, H295R cells
were incubated with adiponectin (100 nM) for 6 h, 12 h, 24 h and 36 h
with an ANG II control (100 nM; 24 h). ELISA analysis of the H295R cell
media (Fig. 2A) showed that a 24 hour stimulation of (100 nM)
adiponectin maximally increased cortisol secretion to 165%±10%
(pb0.01). This signiﬁcant functional outcome was comparable to
(100 nM) angiotensin (200%±8%; pb0.01), a potent standard for
assessing steroidogenesis in this adrenal cell model [16]. Fig. 2C shows
dose-dependent effects of adiponectin on cortisol secretion. Maximal
response occurs between 10 nM and 100 nM treatments.
3.3. Effects of adiponectin on steroid regulatory gene expression in H295R
cells
Quantitative determination of effects of adiponectin (100 nM) on
steroid regulatory genesmeasured at 4 h following stimulation resulted
in a signiﬁcant up-regulation of StAR (165.3%±8; pb0.01), CYP11A
(341.2%±11; pb0.001), 3βHSD (57.3%±4.6; pb0.05), CYP17 (70.3%±
10; pb0.01) and CYP11B1 (185.6%±12; pb0.01). Fig. 2B shows the
changes in mRNA levels of steroidogenic regulatory enzyme genes
following adiponectin treatment.
3.4. Effects of adiponectin on StAR protein expression
The genetic expression data above suggests a clear steroidogenic
pathway for the observed effects of adiponectin on cortisol secretion. To
conﬁrm this at the protein level, we used Western blotting to measure
the effects of adiponectin on the expression of the StAR protein
following stimulation for 4 h and angiotensin (100 nM) was used as) are representative results showing ethidium bromide-stained electrophoresis gel of PCR
bp). C) and D) are representativeWestern blot analysis for ADIPORs protein expression in
egative control lane 3). B) Human subcutaneous adipose tissue (ADR, lane 1,), H295R cells
s adipose tissue lysates, 3)HEK293-ADIPOR1 clone cell lysates, and 4) Laemmli buffer.
2 clone cell lysates, and 4) Laemmli buffer.
Fig. 2. Effects of adiponectin on cortisol secretion and mRNA expression of steroid biosynthesis genes in NCI-H295R cells. Cells were cultured in 6-well plates for at-least 48 h before the
experiment was carried out. Cells were starved overnight in serum free media, and the following day the cells were washed and incubated in fresh serum free media with 100 nM
adiponectin or 100 nMANG for 6 h, 12 h, 24 h and 36 h. A) Timedependent effects of adiponectin on cortisol content of themediumwere determined from cell culture supernatants using
the EIAmethod and represented as percentage changeswith respect to basal. B) For gene expression studies total RNAwas isolated, reverse transcribed to cDNA, and usedas a template for
quantitative PCRusing StAR, CYP11A, 3βHSD, CYP17, CYP21, CYP11B1 andGAPDHspeciﬁc primers. Resultwerenormalised against GAPDHexpressionand expressed aspercentage change
over basal. C) Dose dependent effects of adiponectin on cortisol content of the medium were determined from cell culture supernatants using the EIA method and represented as
percentage changeswith respect to basal. Data points aremeans±SEof values from4different experiments. Signiﬁcancewasdetermined by one-wayANOVA followedwith Tukey test for
post hoc analysis against control cells (*Pb0.05; **Pb0.01).
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angiotensin induced signiﬁcant increases in the expression of StAR
protein. Similar to the cortisol secretion data, this response was
comparable with angiotensin effects (8.9±0.9 fold; pb0.001). Fig. 3A
shows a representative Western blot demonstrating changes in StAR
protein expression following adiponectin treatment. These increases in
StAR protein expression were dose-dependent (Fig. 3B). A concentra-
tion range of 1–200 nM was used for this study showing a maximal
expression at a concentration of 100 nM. Interestingly, at a higherFig. 3. Effects of adiponectin, on StAR protein expression in H295R cells. Western blot analysis o
serum freemediumcontainingdifferent doses of adiponectin, or controlwithout stimulus for 4 h
various doses of adiponectin. Following stimulation cells were washed with ice cold PBS and c
β-actin recognised bands with apparent molecular weights of 30 kDa, and 42 kDa respectively
depicts the results of representative experiment, and the relative intensity (fold increase over
experiments. Data points aremeans±SE from4different experiments. Signiﬁcancewasdeterm
(**Pb0.01).concentration the StAR protein expression recedes towards basal levels.
Fig. 3B shows a representative Western blot showing dose dependent
effects of adiponectin on StAR protein expression.
3.5. Adiponectin signals through the AMPK, AKT, and ERK1/2 MAPK
pathways, but not p38 in H295R cells
The downstream effects of adiponectin agonists are known to be
mediated by two membrane bound receptors ADIPOR1 and ADIPOR2.f protein extracts fromH295R cells for StAR protein expression. Cells were incubatedwith
.A) Cells stimulatedwith either adiponectinof 100 nMANG.B)Cellswere stimulatedwith
ell lysis was made and used for Western blotting analysis. The antibody against StAR and
. Densitometric analysis of StAR protein expression was normalised to β-actin. The ﬁgure
basal) was measured by densitometry using a Scion image software from 4 independent
inedbyone-wayANOVA followedwithTukey test for post hoc analysis against control cells
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members of theMAPK family in a number of tissues and cellularmodels
[18–20] and the N-terminal region of adiponectin has been shown to
activate several pathways including ERK1/2 activation [21] and the
COX2 expression [22]. Activation of some of these signalling cascades is
crucial for the survival of adrenal cells. We employed Western blot
analysis to testwhether adiponectin-stimulation ofH295R cells induced
activation of AMPK, AKT, ERK1/2 and p38 MAPK. Time-dependent
studies showed adiponectin activated theAMPK,AKT andERK1/2MAPK
pathways (Fig. 4A andB).However therewasnoactivation of p38MAPK
either in a time- (Fig. 4C) or concentration-dependent manner
(Supplementary Fig. 1). 100 nM adiponectin-stimulated ERK1/2 activa-
tion peaked (5-fold) after 10 min and remained signiﬁcantly higher
than the basal levels even after 60 min (2.5 fold, Fig. 4A). Activation of
AMPK was slightly delayed peaking at about 20 min (2-fold) and
remained signiﬁcantly higher levels than basal even at 60 min.
3.6. The effects of AMPKi and ERKi on adiponectin-mediated StAR protein
expression and cortisol secretion
It is known that adiponectin leads to the activation of ERK1/2 and
AMPK through one or both of the ADIPORs. To assess the involvement of
the above mentioned key signalling molecule involvement in adipo-
nectin mediated StAR protein expression, we compared the relative
StAR expression in response to adiponectin stimulation in the presence
and absence of U0126 (MEK1/2/ERK1/2 inhibition) and compound-C
(AMPK inhibition) in our experimental design. The data in Fig. 5A and B
showed that both ERKi (from 4.5±0.36-fold to 2.3±0.20-fold over
inhibitor alone) and AMPKi (from 3.4±0.36-fold to 2.3±0.20-fold
inhibitor alone) led to a partial reduction of StAR protein expression in
response to adiponectin. For cortisol secretion studies, U0126 (1 and
10 μM) alone showed a slight elevation in basal however the raise in
cortisol secretion induced by U0126 alone was not statistically
signiﬁcant, at either concentrations (Fig. 5C). Compound C aloneFig. 4. Time dependent effects of adiponectin, on ERK1/2, p38, AMPK and AKT protein phosphor
following stimulation with 100 nM adiponectin for various time points were analysed for ER
recognised bands with apparentmolecular weights of 42 and 44 kDa. p-p38 and p38 recognise
with apparent molecular weights of 63 kDa. p-AKT and AKT recognised bands with appare
normalised to total protein content. The ﬁgure depicts the representative experiment; the
independent experiments. Data points are means±SE, where basal was considered as one for
one-way ANOVA followed with Tukey test for post hoc analysis against control cells (**Pb0.01(1 μM) showed no signiﬁcant changes on basal cortisol levels however
compound C (10 μM) induced signiﬁcant reduction on basal cortisol
levels (Fig. 5D). The data from this study demonstrate that there is a
signiﬁcant increase in cortisol secretion in the combination treatment
group of U0126+adiponectin compared to the U0126 alone treated
group (Fig. 5C). However the combined effects were signiﬁcantly lower
compared to adiponectin-induced cortisol effects on basal cortisol
secretion.
Further studies involving inhibitionof AMPKonadiponectin induced
cortisol secretion depict that compound C-inhibition of AMPK results in
a signiﬁcant reduction in cortisol secretion compared to adiponectin-
induced cortisol secretion alone (Fig. 5D).
3.7. Adiponectin is not proliferative and has a small effect on apoptosis
Earlier studies from Ehrhart-Bornstein [23] reported a detachment of
H295R cells following stimulation with adiponectin. To eliminate the
possibility of induction of apoptosis in H295R by adiponectin, we studied
the effects of adiponectin on proliferation and apoptosis. Stimulation of
H295R cells with 100 nM adiponectin showed no signiﬁcant changes in
H295R cell proliferation after a 24 hour stimulation (Fig. 6A). However
DNA fragmentation assay (marker of apoptosis) assessing the effects of
adiponectin on apoptosis at 24 h showed a slight increase in apoptosis of
H295R cells but was not signiﬁcant. Camptothecin (used as positive
control for the study) showed a signiﬁcant increase in apoptosis (350%)
compared to the control stimulation. This data is interesting as we
observed a signiﬁcant, transient increase on AKT activation in response to
adiponectin (Fig. 4D)whichpeakedat about10 min (2-fold) and returned
to near basal by 20 min.
4. Discussion
Adiponectin is a recently discovered adipokine, circulating in the
plasma in the range of 3 to 30 μg/ml (100 nM–1 μM) concentration inylation inH295R cells.Western blot analysis of protein extracts prepared fromH295R cells
K1/2, p38, AMPK and AKT phosphorylation. The antibody against p-ERK1/2 and ERK1/2
d bands with apparentmolecular weights of 38 kDa. P-AMPK and AMPK recognised bands
nt molecular weights of 60 kDa. Densitometric analysis of phosporylated proteins was
relative intensity was measured by densitometry using a Scion image software from 3
each experiment, and fold increase over basal is shown. Signiﬁcance was determined by
; ***Pb0.01).
Fig. 5. Comparing the StARprotein expression and cortisol secretion fromH295R cells in thepresence and absenceofMEK1/2 andAMPKi pathway inhibitors. The indicated inhibitorswere
added toH295Rcells (∼70% conﬂuence) in6-well plates and incubated for at least 60 min. Cellswere then cultured for the indicatedperiods in response to adiponectin: (A)MEK1/2/ERK1/
2-inhibition stimulated by 100 nm adiponectin. (B) AMPKi stimulated by 100 nM adiponectin, and angiotensin-stimulated StAR expression was included as a positive control for
approximatemaximum expression. StAR levels were determined and quantiﬁed byWestern blot exactly as described for Fig. 3. (C) Cortisol secretion fromH295R cells in the presence of
MEK1/2/ERK1/2-inhibition stimulated by 100 nm adiponectin (D). Cortisol secretion from H295R cells in the presence of AMPKi stimulated by 100 nM adiponectin, and angiotensin-
stimulated StAR expressionwas included as a positive control for approximatemaximumexpression. StAR levelswere determined and quantiﬁed byWestern blot exactly as described for
Fig. 3. Cortisol release from H295R cells was determined from cell culture supernatants using EIA method. Data points are means±SE from six independent experiments. Signiﬁcant
difference from basal and adiponectin-stimulated expression was determined by one-way ANOVA followed with Tukey test for post hoc analysis (*, Pb0.01; ***, Pb0.001). Signiﬁcance
between stimulated expression±inhibitors is indicated (#, Pb0.05; and b, Pb0.01).
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endocrine manner at concentrations sufﬁcient to induce adrenal
steroidogenesis. Also intra-adrenal adipose tissue depots in direct
contact with steroid-producing adrenocortical cells could act as local
sources of adipokines. This close cellular proximity forms the prereq-
uisite for paracrine interactions and indicates a direct stimulation of
steroidogenesis by adipokines [23]. Adipokines can stimulate aldoste-
rone synthesis and secretion in an endocrine or paracrine manner with
implications for hyperaldosteronism and consequently hypertension in
obesity [6]. The functional importance of adiponectin receptor activa-
tion in the adrenal gland is not well studied.
In this current study, we demonstrate for the ﬁrst time the expression
of ADIPOR1 and ADIPOR2 mRNA and protein in human adrenocortical
H295R cells. More importantly, we show stimulation of H295R cells withFig. 6. Effects of adiponectin on H295R cell viability. H295R cells were cultured for 24 h in gro
were cultured in serum free media overnight. Effects of adiponectin on H295R cell A) prolifer
of vehicle alone. Data points are expressed as percentages of untreated cells (100%); mean
These data show 100 nM adiponectin neither induced proliferative nor pro-apoptotic effects
for post hoc analysis PN0.001 compared with untreated cells.adiponectin results in increased expression of many steroidogenic genes,
StAR protein expression, cortisol secretion and the signalling cascades
involved in the regulation of StAR protein expression.
The regulation of the adrenal steroidogenic machinery is a complex
process that involves the interaction of diverse hormones and multiple
signalling pathways that coordinate the cooperation and interaction of
transcriptional machinery as well as a number of post-transcriptional
mechanisms that govern mRNA and protein expression [24]. Although
ACTH and angiotensin are the major regulators of adrenal steroid
production, recent evidences point out the importance of adipokines in
ﬁne tuning the regulation of steroidogenesis process [25–27].
Our ﬁndings on investigating the effects of adiponectin stimulation in
H295R cells showed a signiﬁcant increase in cortisol production, together
with increases in mRNA levels of key steroidogenic genes including StAR,wthmedia in 96well plates (1×104 cells per well in quadruplet) prior to treatment cells
ation and B) apoptosis were assessed. Control cells were treated with the same amount
±SE, from three independent experiments each performed in quadruplicate samples.
on H295R. Signiﬁcance was determined by one-way ANOVA followed with Tukey test
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StAR protein expression is the ﬁrst rate limiting step in the steroid
biosynthesis in the adrenal gland, as StARprotein promotes the transfer of
cholesterol across the mitochondrial membrane for steroid biosynthesis
to take place [24,28,29]. Thereforewe performed comprehensive analysis
of effects of adiponectin and the key signalling events involved in the
regulation of StAR protein expression upon stimulationwith adiponectin.
Stimulation of H295R cells with adiponectin resulted in a signiﬁcant
increase in StAR protein expression. The bell-shaped effect of dose-
dependent adiponectin on StAR expression was particularly interesting
due to the inverse relationship between circulating adiponectin levels and
obesity. Adiponectin concentrations similar to those of endogenous
adiponectin found in obese people resulted in a higher StAR expression,
suggesting that in obese people ADIPOR activation might play a role in
activating the adrenal cells to produce more cortisol.
Induction of cAMP and the cAMP-dependent signalling mecha-
nisms is undoubtedly the principal pathway regulating StAR expres-
sion and steroid biosynthesis [30–32]. Activation of two key MAPKs
(ERK1/2 and p38) and AMPK is also involved in the regulation of StAR
expression and steroid production. However, the precise mechanism
involved is poorly understood as a consequence of conﬂicting reports
demonstrating stimulation, inhibition, or no effect in different
steroidogenic cells [33–36].
We have shown that stimulation with adiponectin resulted in
signiﬁcant increases in ERK1/2 and AMPK activation in H295R cells. To
elucidate the involvement of ERK1/2 and AMPK in adiponectin induced
StAR expression, MEK/ERK1/2 inhibitor U0126 and the AMPK inhibitor
compound-C were used. These inhibitors have been widely used for
blocking relevant signalling pathways in other steroidogenic cells
[11,37]. Inhibition of both ERK1/2 and AMPK pathways resulted in
partial but signiﬁcant reductions in adiponectin-induced StAR expres-
sion suggesting that these two major pathways may be involved in
regulating StAR expression inH295R cells. Angiotensin (used as positive
control throughout the study) also showed signiﬁcant increase in StAR
expression, however when adiponectin was co-incubated with angio-
tensin there was no additive/synergistic effect observed. This data
shows that adiponectin-induced cortisol secretion involves both AMPK
and ERK1/2 dependent pathways. However, the combined effects of
adiponectin with either inhibitors did not completely reduce the
secretion of cortisol to basal levels. This may reﬂect that there exists a
small effect of an AMPK and ERK1/2-independent mechanism for
adiponectin-induced cortisol secretion.
Whilst a previous study suggested that cortisol secretion was not
observed in a screen of potential mineralocorticoid-releasing factors
including “adiponectin” [23], the study does notmentionwhich form of
adiponectin was used in their studies, and they reported possible
cellular necrosis with 100 nM adiponectin treatment. Our studies with
the same concentration of adiponectin (100 nM) did not show any cell
detachment/necrosis nor showed any signiﬁcant induction of apoptosis
or reduction in cell viability.
Altogether our data implicates that the ADIPORs are clearly expressed
in a pluripotent H295R adrenal cell model. We show that stimulation of
H295R cells with adiponectin results in increased cortisol secretion. This
effect is accompanied by the increased gene expression of several key
members of the steroidogenic pathway including the expression of StAR
proteinviaERK1/2andAMPK-dependentpathways. Thishas implications
for our understanding of adiponectin receptor activation and peripheral
steroidogenesis. Furthermore adiponectinmightplay an important role in
the pathophysiology of adrenal secretions in obese people.
Supplementarymaterials related to this article canbe foundonlineat
doi:10.1016/j.bbamcr.2011.02.010.
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